[Thromboembolism prevention in surgery. Results with panthesin-hydergin (PH 203) in 1048 patients].
D010129:4-Aminobenzoic Acid / Q000628:therapy*; D004088:Dihydroergotoxine; D004338:Drug Combinations; D004876:Ergot Alkaloids / Q000628:therapy*; D007930:Leucine / Q000031:analogs & derivatives; D011343:Procaine / Q000031:analogs & derivatives; D013923:Thromboembolism / Q000517:prevention & control*; D062366:para-Aminobenzoates
D004338:Drug Combinations; D004876:Ergot Alkaloids; C006783:dihydroergotoxin, p-aminobenzoyl-N-diethyl-leucinol drug combination; D062366:para-Aminobenzoates; D004088:Dihydroergotoxine; D011343:Procaine; C005426:leucinocaine mesylate; D007930:Leucine; D010129:4-Aminobenzoic Acid
ERGOT ALKALOIDS/therapy; PARA-AMINOBENZOIC ACID/therapy; THROMBOEMBOLISM/prevention and control